Breaking News

ANI Launches Indapamide Tablets

Company continues to leverage U.S.-based manufacturing assets

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ANI Pharmaceuticals has launched indapamide tablets in 1.25mg and 2.5mg doses. Indapamide is used in the treatment of hypertension and swelling associated with congestive heart failure. The annual U.S. market for Indapamide Tablets is approximately $9 million, per IMS Health. This marks the second product that ANI is launching from the basket of 22 previously marketed generic products that it acquired in July 2015. “This launch represents yet another successful manufacturing site transfer ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters